Susceptibility Tests
|
|
- Meryl King
- 5 years ago
- Views:
Transcription
1 JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1982, p Vol. 16, No /82/ $02.00/0 In Vitro Studies with Cefotaxime: Disk Diffusion Susceptibility Tests SMITH SHADOMY* AND EDWARD L. CHAN Department of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia Received 22 February 1982/Accepted 29 April 1982 Until recently two sets of conflicting interpretive criteria existed for use with the standardized 30-,ug cefotaxime diffusion disk [National Committee for Clinical Laboratory Standards (NCCLS) M2-A2S, supplement 1; product information package insert for Claforan (cefotaxime sodium), edition 10/81.] The latter criteria recently were superseded by a third set which differs radically from the first two in both minimal inhibitory concentration (MIC) and zone size breakpoints. The first two sets of criteria differed mainly in the zone of inhibition diameters used to predict resistant and intermediate organisms. The accuracies of these two sets of criteria were evaluated by paired agar dilution (World Health Organization- International Collaborative Study) and disk diffusion tests (Food and Drug Administration) with 347 clinical isolates of aerobic bacteria. A total of 274 isolates (79%) were clinically susceptible by agar dilution as defined by NCCLS (MIC.8,ug/ml) and 61, including 48 Pseudomonas spp., were of intermediate susceptibility (MIC of 16 or 32 p,g/ml). Twelve were resistant (MIC.64,ug/ml). The original product information package insert criteria proved to be most unreliable in identification of the intermediate organisms (zone of inhibition diameters of 18 to 22 mm); only 5 were correctly predicted as being intermediate, whereas 54 were predicted as being resistant, and 2 were predicted as being susceptible. In contrast, the NCCLS criteria (zone of inhibition diameter of 15 to 22 mm) predicted 41 as being intermediate and 18 as being resistant; again, 2 were susceptible. The 12 isolates resistant to cefotaxime by agar dilution were correctly predicted to be resistant by either set of breakpoints (zone of inhibition diameter of.14 or.17 mm). These results suggest that the package insert criteria previously recommended for use with the 30-,ug cefotaxime disk were overly conservative and required revision to bring them into agreement with NCCLS performance standards. Unfortunately however, the recent revision of the package insert criteria has further confused this issue [product information package insert for Claforan (cefotaxime sodium), edition 2/82]. Cefotaxime (HR 756; CTX) is a broad-spectrum cephalosporin antibiotic possessing a high degree of resistance to,-lactamases (4, 7). It is intended for parenteral use in treatment of serious infections caused by susceptible organisms, both gram-negative and gram-positive. The in vitro spectrum of CTX includes many organisms resistant to other cephalosporins and penicillins (9). Because of this extended spectrum, a separate 30-,ug CTX disk has been developed for use in disk diffusion susceptibility tests. Until recently, two sets of interpretive "breakpoint" criteria had been promulgated for use with the 30-,ug CTX disk. One set comprises those included in the standards recently proposed by the National Committee for Clinical Laboratory Standards (NCCLS; 8). These standards agree with and appear to be derived from those proposed by Fuchs et al. (3). The second set of 213 criteria comprises those previously contained in the product information package insert for Claforan (CTX sodium; 5). These two sets of criteria differed primarily in the zone of inhibition diameters used to define intermediate and resistant organisms (Table 1). In terms of corresponding minimal inhibitory concentration (MIC) values, both sets of criteria regarded 8,ug/ml as the upper limit of probable clinical susceptibility. In terms of clinical resistance, NCCLS defines this as an MIC.64 p.g/ml, whereas the package insert used an MIC of >16 jig/ml. Left undefined by these criteria is the intermediate, or indeterminate, category as suggested by Fuchs et al. (3), which, by default, appears to be 16 or 32,ug/ ml. The study reported here had two specific goals: evaluation of the performance characteristics of the 30-,ig CTX disk and evaluation of the reliability of each of the two sets of criteria
2 214 SHADOMY AND CHAN TABLE 1. Interpretive criteria for use in disk diffusion susceptibility tests with the 30-Rg CTX disk Category Zone diam (mm) breakpoints Claforan package insert criteria (10/81 NCCLS interpretive standards edition) Susceptible.23 (.8)" 23 (s8) Intermediate Resistant.17 (>16) <14 (.64) a Corresponding MIC (pg/ml). previously promulgated for use in interpretation of results obtained with this disk as well as those now contained in the revised Claforan product information package insert (6). MATERIALS AND METHODS Organisms. A total of 347 isolates of gram-negative and gram-positive aerobic bacteria were tested. These included 78 organisms collected from several different medical centers in this country, as well as a diverse population of gram-negative organisms of Asiatic origin. Identifications of all isolates were confirmed by either accepted laboratory criteria (2, 7) or the API 20E system (Analytab Products) as required. Stock cultures were maintained in cystine Trypticase (BBL Microbiology Systems) agar medium (CTA medium). Susceptibility tests. Paired agar dilution and disk diffusion tests were performed with all 347 isolates. The agar dilution tests employed the World Health Organization-International Collaborative Study procedure as described by Washington and Sutter (10); final test concentrations of CTX (HR 756, Hoechst-Roussel Pharmaceuticals, Inc.; lot 17011) ranged from 0.13 to 64,ug/ml. The medium employed in the agar dilution tests was a commercial dehydrated Mueller-Hinton agar (MH; BBL). The disk diffusion tests were performed by the standardized Food and Drug Administration procedure as described by Barry and Thornsberry (1). A standardized 30-p.g CTX disk (BBL; lot , assayed content of 30 pg) and commercially prepared 150-mm-diameter MH plates (MH-11; BBL) were used in the disk diffusion tests. Inocula for the disk diffusion tests were prepared from overnight broth cultures and then adjusted to match the turbidity of a 0.5 MacFarland standard. Inocula for the agar dilution tests were prepared to contain approximately 2 x 106 colony-forming units per ml or 5 x 103 colony-forming units per spot. Both agar dilution and disk diffusion tests then were performed. Inoculated plates were incubated overnight at 35 C. The MIC was defined as being the lowest concentration of drug yielding no more than one or two colonies; barely discernable or hazy responses were ignored. Zones of inhibition in the disk diffusion tests were measured in triplicate to the nearest 0.1 mm and averaged. Data analyses. Original data were evaluated in terms of numbers of organisms inhibited at each given concentration of CTX and their corresponding zones of inhibition. All measurable zones of inhibition for each given concentration were then averaged. Results of J. CLIN. MICROBIOL. the paired tests then were analyzed in terms of each tested drug concentration (log2 value) and the corresponding average zone of inhibition using standard regression analysis (least-squares method). Statistics from this analysis were then used to derive disk diffusion zone size correlates for MIC values of 8 (susceptible) and 64 (resistant) p.g/ml. Finally, individual paired zone size and MIC responses were analyzed in terms of agreement between actual MIC values and susceptibility categories as predicted by the corresponding zone size responses. Three sets of criteria were used in this analysis: the two previously published sets of zone size criteria described above (5, 8) and the zone size criteria now contained in the current edition of the Claforan product information package insert (6). RESULTS In vitro susceptibility data. A total of 274 isolates had CTX MIC values of 8 jig/ml or less. Thus, by NCCLS MIC standards, these were susceptible organisms (Table 2). A total of 61 isolates had MIC values of 16 or 32 plg/ml and thus were of intermediate or indeterminant susceptibility. Ten isolates were clinically resistant, with MIC values of 64 plg/ml, and 2 more were totally resistant (MIC >64 ptg/ml). Isolates of Pseudomonas spp. accounted for 68 of the 73 organisms in the latter two categories. Regression analysis. The average zones of inhibition for all isolates inhibited at each given drug concentration were calculated (Table 2). Data for several isolates were rejected from these calculations because of either apparent noncongruency, two values, or nonmeasurable values (no measurable zone of inhibition or MIC values of >64,ug/ml, seven values). Regression analysis was then performed, matching the log2 value of each concentration against the average zone TABLE 2. In vitro susceptibility to CTX as determined by paired agar dilution and disk diffusion tests Drug No. Avg zone of Excluded (pg/mi) inhibited inhibition data" > a Data rejected from further regression analysis: contamination, two values; no measurable zones or MICs >64,g/ml, seven values.
3 VOL. 16, 1982 CEFOTAXIME DISK DIFFUSION TESTS 215 of inhibition for that concentration. Results of this analysis indicated excellent correlation (r = , P < 0.001; Fig. 1). Regression statistics a(26.78) and r( ) then were used to calculate disk diffusion zone size correlates for MIC values of 8 (Y, = mm) and 64 (YI. = mm) p.g/ml. These values were rounded to 20 and 14 mm, respectively, leaving an intermediate region of 15 to 19 mm. Analysis of disk diffusion test results. Paired MIC and disk diffusion test data were analyzed for all 347 isolates. According to MIC data, using NCCLS standards, there were three groups of organisms: resistant (MIC.64,ug/ml), 12; intermediate (MIC of 16 or 32,ug/ml), 61; susceptible (MIC s8,ug/ml), 274. Application of the zone size breakpoints generated by these same data correctly predicted the probable category of susceptibility for 315 isolates (91%). Incorrect predictions involved 22 isolates that were intermediate by MIC and 10 isolates that were susceptible by MIC. Of the 22 intermediate isolates, 4 were predicted to be susceptible, and 18 were predicted to be resistant. Of the 10 isolates susceptible by MIC, 3 were predicted to be resistant, and 7 were predicted to be intermediate. Results similar to those above were obtained when the NCCLS interpretive zone size standards were applied (Table 3). Both sets of data were in agreement for 309 (89%) isolates. There were 38 instances of disagreement between mea <1I O O ( -I_ -2-3i I sured MIC values and interpretation of zone size responses. The isolates for which data were inconsistent involved 20 intermediate by MIC and 18 susceptible by MIC. Of the intermediate organisms, two were predicted by the disk test as being susceptible, and 18 were predicted as being resistant. The latter were the same organisms predicted as being resistant with the regression statistics correlates. Two isolates each of Pseudomonas spp. and Escherichia coli and one isolate each of Enterobacter spp. and Proteus mirabilis, susceptible by MIC and predicted as being susceptible by the regression statistic correlates, now were placed in the intermediate category. Application of the original package insert criteria to the results of the disk diffusion tests resulted in 74 (21%) instances of disagreement between paired MIC and disk diffusion test data. Three isolates of Pseudomonas susceptible by MIC and predicted as being intermediate by the NCCLS standards now were predicted to be resistant. More importantly, 38 isolates intermediate by MIC now were placed in the resistant category. Only 5 (8%) of the 61 isolates intermediate by MIC were predicted as being intermediate by these criteria. Recently and subsequent to the performance of these studies, the package insert criteria were revised (6). The revision suggests use of MIC respectively, to define clinical susceptibility and resistance. Or- values of -16 and.64 jig/ml, 41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ E 2 3(8) \ 1 2 I I1 1 2 I I K I I I I I I I I I 1 I I I I I 1 I I I I I I slo >38 ZONE OF INHIBITION (AVG. Z.D.,ea MIC), mm, 30-pg CTX DISC FIG. 1. Correlation between CTX agar dilution MIC values and zones of inhibition obtained with a 30-,ug CTX diffusion disk. Numbers reflect distribution of individual zone size responses (rounded to nearest millimeter). Z.D., Zone diameter.
4 216 SHADOMY AND CHAN J. CLIN. MICROBIOL. TABLE 3. Analysis of disk diffusion test results-correlation of MIC responses with results of disk diffusion tests using three different sets of interpretive criteria No. in category by:a CTX MIC (p.g/ NCCLS zone size standards with Original package insert criteria, Revised package insert criteria, ml) (no. zone size diam (mm) of: 10/81 edition, with zone size diam 2/82 edition, with zone size diam inhibited) Res. Intermed. Suscept. Res. Intermed. Suscept. Res. Intermed. Suscept > (12) (16) (45) (11) c4(263) a Res, Resistant; Intermed., intermediate; suscept., susceptible. ganisms having MICs between 16 and 64,ug/ml are defined as being "... susceptible if high dosage is used or if the infection is confined to tissues... in which high antibiotic levels are attained (6)." The corresponding zone size correlates are as follows: susceptible,.20 mm; intermediate, 15 to 19 mm; resistant, <14 mm. These new zone size and MIC criteria were applied to the previously described data with the following results (Table 3). Of 274 organisms having MIC values of 8 jig/ml or less, the new zone size correlates predicted 264 (96%) to be susceptible and 10 to be resistant or intermediate. However, of 45 organisms having MIC values of 16,ug/ml and now considered to be susceptible by MIC, only 4 were predicted to be susceptible by the disk test, whereas 30 were predicted to be intermediate, and 11 were predicted to be resistant. Of the latter 41 organisms, 39 were isolates of Pseudomonas. Most instances of disagreement between measured MIC values and categories of susceptibility predicted by the 30-,ug CTX disk diffusion test involved isolates of Pseudomonas spp. (Table 4). Paired data for 78 such isolates were analyzed. Ten isolates were resistant by MIC; all 10 were correctly predicted as being resistant by the NCCLS standards and both sets of package insert criteria. Ten were susceptible to 8,ug/ ml or less; only two were correctly predicted as being susceptible by either the NCCLS criteria or the original package insert criteria. The original package insert criteria predicted resistant for two and intermediate for six of the remaining eight, whereas the NCCLS standards predicted intermediate for all eight. A total of 58 Pseudomonas isolates had intermediate CTX MIC values as defined by NCCLS, 15 at 32 p.g/ml and 43 at 16,ug/ml. Application of the NCCLS standards to the disk diffusion test data for these 58 isolates correctly predicted 40 (70%) as being intermediate; two were predicted to be susceptible, and 16 were predicted to be resistant. In contrast, when the original package insert criteria were applied, 52 (90%) were predicted to be resistant, with only 4 as being intermediate and two as being susceptible. Only confusion resulted when the revised package insert criteria were applied to the data for Pseudomonas spp. According to the revised MIC criteria, 53 isolates could be considered to be susceptible. The disk test data predicted the following for these 53 isolates: susceptible, 8; intermediate, 34; resistant, 11. Of 15 isolates now intermediate by MIC, the disk test data predicted 10 to be intermediate and 5 to be resistant. TABLE 4. Performance of the 30-p.g CTX disk in disk diffusion tests with 78 isolates of Pseudomonas spp. No. in category by:a CTX MIC (,ug/ NCCLS zone size standards with Original package insert criteria, Revised package insert criteria, C mlc(n.g/ NCCS zone size stan s w 10/81 edition, with zone size diam 2/82 edition, with zone size diam m') (no. zone size diam (mm) of: (mm) of: '(mm) of: inhibited) Res. Intermed. Suscept. Res. Intermed. Suscept. Res. Intermed. Suscept > (10) (15) (43) (8) '4(2) a See Table 3, footnote a for abbreviations.
5 VOL. 16, 1982 DISCUSSION Two conclusions can be drawn from the results of this study. First, the zone size criteria previously recommended by the Claforan product information package insert (5) for use with the 30-,ug CTX disk diffusion test were overly conservative. This applied primarily to organisms of intermediate or indeterminate susceptibility (MICs of 16 or 32 jig/ml). Many such organisms will be predicted by disk diffusion testing to be resistant when these older criteria are applied. Revision of the package insert zone size criteria, bringing them in line with current NCCLS standards for the 30-,ug CTX disk, would have been desirable. Unfortunately, the recent revision of these criteria now differs from NCCLS standards in both MIC and zone size criteria. This only adds confusion to the issue. Second, disk diffusion susceptibility tests with the 30-,Ig CTX disk and isolates of Pseudomonas spp. appear to be a most unreliable way of predicting probable clinical susceptibility or resistance regardless of which criteria are used. More importantly, and as already cautioned by others (3), sufficient clinical experience does not yet exist to permit definition of absolute in vitro breakpoints for CTX and Pseudomonas spp. For these reasons it is recommended that results of disk diffusion tests with the 30-,ug CTX disk not be used in making therapeutic decisions regarding Pseudomonas spp. and CTX. LITERATURE CITED 1. Barry, A. L., and C. Thornsberry Susceptibility testing: diffusion test procedures, p In E. H. Lennette, A. Balows, W. J. Hausler, Jr., and J. P. Truant CEFOTAXIME DISK DIFFUSION TESTS 217 (eds.), Manual of clinical microbiology, 3rd ed. American Society for Microbiology, Washington, 2. R. R. Facklam Streptococci and aerococci, p In E. H. Lennette, A. Balows, W. J. Hausler, Jr.. and J. P. Truant (eds.), Manual of clinical microbiology, 3rd ed. American Society for Microbiology. Washington, 3. Fuchs, P. C., A. L. Barry, C. Thornsberry, R. N. Jones, T. L. Gavan, E. H. Gerlach, and H. M. Sommers Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing. Antimicrob. Agents Chemother. 18: Heymes, R., A. Lutz, and E. Schrinner Experimental evaluation of HR 756, a new cephalosporin derivative, p In W. Siegenthaler and R. Luthy (ed.), Current chemotherapy. American Society for Microbiology, Washington, 5. Hoechst-Roussel Pharmaceuticals, Inc Claforan (cefotaxime sodium) Sterile. Product information package insert, ed. 10/81. Hoechst-Roussel Pharmaceuticals, Inc.. Somerville, N.J. 6. Hoechst-Roussel Pharmaceuticals, Inc Claforan (cefotaxime sodium) Sterile. Product Information package insert, ed. 2/82. Hoechst-Roussel Pharmaceuticals, Inc.. Somerville, N.J. 7. Kloos, W. E., and P. B. Smith Staphylococci, p In E. H. Lennette, A. Balows, W. J. Hausler. Jr., and J. P. Truant (ed.), Manual of clinical microbiology, 3rd ed. American Society for Microbiology, Washington, 8. National Committee for Clinical Laboratory Standards Subcommittee on Antimicrobial Disc Susceptibility Testing Performance standards for antimicrobic disc susceptibility tests, 2nd ed., first supplement (NCCLS standard M2-A2). National Committee for Clinical Laboratory Standards Publication 1: Peters, G., and G. Pulverer Comparative in vitro activity of cefotaxime (HR 756). Chemotherapy 27: Washington, J. A., and V. L. Sutter Dilution susceptibility test: agar and macro-broth dilution procedures. p In E. H. Lennette, A. Balows, W. J. Hausler. Jr., and J. P. Truant (ed.), Manual of clinical microbiology, 3rd ed. American Society for Microbiology, Washington,
Disk Diffusion Method for Susceptibility Testing of
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1991, p. 1604-1609 0095-1137/91/081604-06$02.00/0 Copyright 1991, American Society for Microbiology Vol. 29, No. 8 Disk Diffusion Method for Susceptibility Testing
More informationStability of Antibiotics and Chemotherapeutics in
APPUED MICROBIOLOGY, Sept. 1970, p. 447-451 Copyright 1970 American Society for Microbiology Vol. 20, No. 3 Printed in U.S.A. Stability of Antibiotics and Chemotherapeutics in Agar Plates KENNETH J. RYAN,
More information1. Procedure for Antibiotic susceptibility test by disc diffusion analysis
Nanoparticles Functionalized with Ampicillin Destroy Multiple Antibiotic Resistant Isolates of Pseudomonas aeruginosa, Enterobacter aerogenes and Methicillin Resistant Staphylococcus aureus Ashley Brown
More informationEvaluation of a Rapid Bauer-Kirby Antibiotic Susceptibility
ANTIMICROBIAL AGENTS AND CHEMoTHERAPY, Mar. 1975. p. 250-255 Copyright 0 1975 American Society for Microbiology Vol. 7, No. 3 Printed in USA. Evaluation of a Rapid Bauer-Kirby Antibiotic Susceptibility
More informationRate of Penicillin Killing of Staphylococcus aureus and
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1982, p. 27-274 95-1137/82/227-5$2./ Vol. 15, No. 2 Rate of Penicillin Killing of Staphylococcus aureus and Autobac 1 Susceptibility Test Results JO-ANN HARRIS' AND
More informationAntibiotic Susceptibility Testing (ABST/AST)
Antibiotic Susceptibility Testing (ABST/AST) Goal Offer guidance to physicians in selecting effective antibacterial therapy for a pathogen in a specific body site. Performed on bacteria isolated from clinical
More informationFactors Influencing Detection of Tolerance in Staphylococcus aureus
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 1982, p. 364-368 Vol. 22, No. 3 0066-4804/82/090364-0$02.00/0 Copyright 1982, American Society for Microbiology Factors Influencing Detection of Tolerance in
More informationIn Vitro Activity of Coumermycin A1
APPLIED MICROBIOLOGY, Nov. 1969, p. 69-7 Vol. 1, No. 5 Copyright 1969 American Society for Microbiology Printed in U.S.A In Vitro Activity of Coumermycin A1 JOSEPH FEDORKO, SOL KATZ, AND HEDI ALLNOCH Bacteriology
More informationABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18
M26-A ISBN 1-56238-384-1 September 1999 ISSN 0273-3099 Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline Volume 19 Number 18 Arthur L. Barry, Ph.D. William A. Craig,
More informationTesting: Evaluation of Overnight Agar Cultures and the Rapid Inoculum Standardization System
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1983, p. 45-457 95-1137/83/345-8$2./ Copyright 1983, American Society for Microbiology Vol. 17, No. 3 Inoculum Standardization in Antimicrobial Susceptibility Testing:
More informationDetermination of MIC & MBC
1 Determination of MIC & MBC Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism after overnight
More informationDetermination of MIC & MBC
1 Determination of MIC & MBC Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism after overnight
More informationLab Three :. Sensitivity test:
Lab Three :. Sensitivity test: Or Diffusion Test: Antibiotic sensitivity test: is a laboratory method for determining the susceptibility of organisms to therapy with antibiotics, Antibiotic susceptibility
More informationMeropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group
Journal of Antimicrobial Chemotherapy (99) 7, 599-606 Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group J. A. Garcia-Rodriguez, J. E. Garcia Sanchez,
More informationChapter 9 Antimicrobial Susceptibility Testing (Agar Disk Diffusion Method)
Chapter 9 Antimicrobial Susceptibility Testing (Agar Disk Diffusion Method) The disk diffusion method presented in this chapter has been carefully standardized by the National Committee for Clinical Laboratory
More informationInvestigational New Drug - Groundwork for in vitro antimicrobial susceptibility testing
Investigational New Drug - Groundwork for in vitro antimicrobial susceptibility testing Erika Matuschek, Ph D Lead Scientist/Operational Manager EUCAST Development Laboratory (EDL) Växjö, Sweden ASM/ESCMID
More informationEM021. Co-Trimoxazole Ezy MIC TM Strip (COT)( mcg/ml) (Trimethoprim/ Sulphamethoxazole) Antimicrobial Susceptibility Testing
Co-Trimoxazole Ezy MIC TM Strip (COT)(0.002-32 mcg/ml) (Trimethoprim/ Sulphamethoxazole) Antimicrobial Susceptibility Testing For In Vitro Diagnostic use EM021 Not for Medicinal Use It is a unique MIC
More informationWe have noticed considerable difference in zone. size when methicillin-sensitivity tests on methicillinresistant
J clin Path, 1974, 27, 4 The reliability of methicillin sensitivity tests on four culture media D F J BROWN AND D KOTHAR From the Division of Hospital nfection, Clinical Research Centre, Harrow, Middlesex,
More informationEzy MIC Strip FEATURES AND ADVANTAGES
Imipenem with & without EDTA Ezy MIC Strips (IPM+EDTA/IPM) (Imipenem + EDTA: 1-64 mcg/ml) (Imipenem : 4-256 mcg/ml) Antimicrobial Susceptibility Testing For In Vitro Diagnostic use EM078 Not for Medicinal
More informationActivity of meropenem and other antimicrobial agents against uncommon Gram-negative organisms
Journal of Antimicrobial Chemotherapy (993) 3, 33-37 Activity of and other antimicrobial agents against uncommon Gram-negative organisms Richard B. Clark and Suzanne E. Joyce Department of Pathology, Crozer-Chester
More informationCI-867, a New Semisynthetic Penicillin: In Vitro Studies
ANTIROBIAL AGENTS AND CHEMOTHERAPY, Dec. 19, p. 939-943 66-44//12-939/5$2./ Vol. 18, No. 6, a New Semisynthetic Penicillin: In Vitro Studies SUSANNE S. WEAVER AND GERALD P. BODEY* Department of Developmental
More informationMIC & Etest. Dr. M. Talebi Ph.D of Bacteriology Tehran University of Medical Sciences
MIC & Etest Dr. M. Talebi Ph.D of Bacteriology Tehran University of Medical Sciences MIC The minimum inhibitory concentration (MIC) is defined as the lowest concentration of the antimicrobial agent required
More information2120 Lab. Week 11. Experiments 13,14,21. Kirby Bauer, TDT, Chemicals
2120 Lab Week 11 Experiments 13,14,21 Kirby Bauer, TDT, Chemicals Controlling Microorganisms Decontamination: Physical, chemical, and mechanical methods to destroy or reduce undesirable microbes in a given
More informationStaphylococcus aureus
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 1980, p. 784-788 0066-4804/80/11-0784/05$02.00/0 Vol. 18, No. 5 Effect of Storage and Changes in Bacterial Growth Phase and Antibiotic Concentrations on Antimicrobial
More informationfor Antifungal Susceptibility Testing of Yeast Isolates
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1994, p. 1992-1996 0095-1137/94/$00+0 Copyright C 1994, American Society for Microbiology Vol., No. 8 Evaluation of a Novel Colorimetric Broth Microdilution Method
More informationfor Antifungal Susceptibility Testing of Yeast Isolates
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1994, p. 1992-1996 0095-1137/94/$00+0 Copyright C 1994, American Society for Microbiology Vol., No. 8 Evaluation of a Novel Colorimetric Broth Microdilution Method
More informationfor Antifungal Susceptibility Testing of Yeast Isolates
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1994, p. 1992-1996 0095-1137/94/$00+0 Copyright C 1994, American Society for Microbiology Vol., No. 8 Evaluation of a Novel Colorimetric Broth Microdilution Method
More informationPostantibiotic effect of roxithromycin, erytfaromycin, and clindamycin against selected Gram-positive bacteria and Haemophilus influenzae
Journal of Antimicrobial Chemotherapy (1987) 20, Suppl. B, 39-46 Postantibiotic effect of roxithromycin, erytfaromycin, and clindamycin against selected Gram-positive bacteria and Haemophilus influenzae
More informationEffect of Storage of Mueller-Hinton Agar Plates on
APPUED MICROBIOLOGY, Sept. 1970, p. 293-297 Copyright 1970 American Society for Microbiology Vol. 20, No. 3 Printed in U.S.A. Effect of Storage of Mueller-Hinton Agar Plates on Zone Sizes for Antimicrobial
More informationKey words: Paracetamol, antibacterial activity, chemical preservative, zone of inhibition.
In Vitro Assessment of Antibacterial Activity of lamatecara Preservatives Abstract: The objective of the current research was to evaluate the efficacy of different preservatives of paracetamol syrup against
More informationIntroduction. Abstract. Journal of Scientific and Innovative Research 2014; 3 (1): Available online at:
Journal of Scientific and Innovative Research 214; 3 (1): 43-48 Available online at: www.jsirjournal.com Research Article ISSN 232-4818 JSIR 214; 3(1): 43-48 214, All rights reserved Received: 19-11-213
More informationNCCLS Standards for Antimicrobial Susceptibility Tests
CE Update Microbiology III NCCLS Standards for Antimicrobial Susceptibility Tests Clyde Thornsberry, PhD T he most requested test of the clinical microbiology laboratory today is probably t h e antimicrobial
More informationQuality Control of Moxalactam Susceptibility Disks
JOURNAL OF CLINICAL MICROBIOLOGY, June 1983, p. 1032-1038 Vol. 17, No. 6 0095-1137/83/061032-07$02.00/0 Copyright 1983, American Society for Microbiology Quality Control of Moxalactam Susceptibility Disks
More informationAntibiotic Susceptibility Testing. Part I
CE Update Microbiology I Antibiotic Susceptibility Testing. Part I Patrick R. Murray, PhD W ith the introduction of antimicrobial c h e m o t h e r a p y in t h e 1940s, the hope of eliminating infectious
More informationDETERMINATION OF THE ID50 VALUES OF ANTIBACTERIAL AGENTS IN AGAR. TAKAKO KATO, SATONORI KURASHIGE, Y. A. CHABBERT* and SUSUMU MITSUHASHI
1299 DETERMINATION OF THE ID50 VALUES OF ANTIBACTERIAL AGENTS IN AGAR TAKAKO KATO, SATONORI KURASHIGE, Y. A. CHABBERT* and SUSUMU MITSUHASHI Department of Microbiology, School of Medicine, Gunma University,
More informationAnalysis of a Single Reference Strain for Determination of. Antibiotic Susceptibility Testing
JOURNAL OF CLNCAL MCROBOLOGY, Nov. 1982, p. 784-793 0095-1137/82/110784-10$02.00/0 Copyright 1982, American Society for Microbiology Vol. 16, No. 5 Analysis of a Single Reference Strain for Determination
More informationBD BBL Mueller Hinton II Agar
BD BBL Mueller Hinton II Agar 111-251177-N-00, December 2014 QUALITY CONTROL PROCEDURES I. INTRODUCTION Mueller Hinton II Agar is used in the standardized disc diffusion procedure for determining the susceptibility
More informationComparison and Evaluation of Carbenicillin Disks in Diffusion Susceptibility Testing
ANTIMICROBiAL AGENTS AND CHEMOTHERAPY, June 1974, p. 599-606 Copyright 0 1974 American Society for Microbiology Vol. 5, No. 6 Printed in U.S.A. Comparison and Evaluation of Carbenicillin Disks in Diffusion
More informationSimplified Method for Antimicrobial Susceptibility Testing of Anaerobic Bacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, OCt. 1975, p. 444-452 Copyright 0 1975 American Society for Microbiology Vol. 8, No. 4 Printed in U.S.A. Simplified Method for Antimicrobial Susceptibility Testing
More informationMethods of Measuring Zones of Inhibition with the Bauer- Kirby Disk Susceptibility Test
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 1979, p. 885-889 0095-1137/79/12-0885/05$02.00/0 Vol. 10, No. 6 Methods of Measuring Zones of Inhibition with the Bauer- Kirby Disk Susceptibility Test ARTHUR L.
More informationRapid Diagnostic Tests for Antimicrobial Resistance: Comparability of Results and Interpretation of Data
Rapid Diagnostic Tests for Antimicrobial Resistance: Comparability of Results and Interpretation of Data Christopher Teale, Animal and Plant Health Agency, UK. 12 th OIE One-Day Seminar, in association
More informationR IC H A R D C. T IL T O N, Ph.D. A N D L IN D A L IE B E R M A N, B.S.
A n n a l s o f C l i n i c a l a n d L a b o r a t o r y S c i e n c e, Vol. 4, No. 3 Copyright 1974, Institute for Clinical Science M icrodilution Assay o f Antibiotics in Body Flu ids R IC H A R D C.
More informationAntibiotic Susceptibility Testing and Data Interpretation
Antibiotic Susceptibility Testing and Data Interpretation Dr Shabbir Simjee Microbiologist Co-Chair CLSI VAST Basingstoke England Bangkok, 7-8 October 2014 For clarity, these are solely my personal views/opinions
More informationBSAC Susceptibility Testing Residential Workshop
BSAC Susceptibility Testing Residential Workshop Susceptibility Testing Methodology Insert name of presentation on Master Slide Mandy Wootton How to determine susceptibility/resistance Minimum Inhibitory
More informationTeicoplanin has not yet been evaluated, but we expect it will perform like vancomycin.
Detection of VISA, GISA, hvisa, VRE, Staphylococci Daptomycin Resistant, and Acinetobacter/Pseudomonas Colistin Resistant, using the Neo Sensitabs prediffusion method. S. aureus CB 182, Susceptible strain.
More informationEvaluation of the E Test for Susceptibility Testing
JOURNAL OF CLINICAL MICROBIOLOGY, OCt. 1991, p. 2197-2203 0095-1137/91/102197-07$02.00/0 Copyright ) 1991, American Society for Microbiology Vol. 29, No. 10 Evaluation of the E Test for Susceptibility
More informationM. Ben-David 1, O. Hammer 1, A.Shinderman 1, Y. Gluckman- Yavo 1, M. Fridman 1, D. Gohman 1, G. Ingber 1 and E. Zahavy 2
437 Fast Antibiotic Susceptibility Testing Utilizing a Unique Spectral Intensity Ratio Analysis via Single Fluorescence Membrane Dye Staining and Flow Cytometry M. Ben-David 1, O. Hammer 1, A.Shinderman
More informationChapter 3. Minimal inhibitory concentration (MIC) test and determination of antimicrobial resistant bacteria
Chapter 3. Minimal inhibitory concentration (MIC) test and determination of antimicrobial resistant bacteria Ruangpan, Lila Date published: 2004 To cite this document : Ruangpan, L. (2004). Chapter 3.
More informationIQCP for Disk Diffusion Antimicrobial Susceptibility Testing (AST)
IQCP for Disk Diffusion Antimicrobial Susceptibility Testing (AST) Test System: Disk Diffusion Antimicrobial Susceptibility Testing (Kirby Bauer) / Twelve Disk Diffusion Test using BBL Disks Facility:
More informationDependability of sensitivity tests in primary culture
J. clin. Path., 1976, 29, 179-184 Dependability of sensitivity tests in primary culture PAMELA M. WATERWORTH AND M. DEL PIANO1 From the Department of Microbiology, University College Hospital, London WCJ
More informationDetermination of Penicillin MICs for Streptococcus pneumoniae by Using a Two- or Three-Disk Diffusion Procedure
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1998, p. 179 183 Vol. 36, No. 1 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Determination of Penicillin MICs for Streptococcus pneumoniae
More informationCONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS
CONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS Specific control measures can be used to kill or inhibit the growth of microorganisms. A procedure which leads to the death of cells is broadly
More informationReceived 23 June 1997/Returned for modification 4 August 1997/Accepted 28 August 1997
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 1997, p. 3198 3202 Vol. 35, No. 12 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Disk Diffusion Test Interpretive Criteria and Quality Control
More informationNworu & Esimone. Division of Pharmaceutical Microbiology, Department of Pharmaceutics, University of Nigeria, Nsukka, , Enugu State
Research Article Nworu & Esimone Tropical Journal of Pharmaceutical Research, December 2006; 5 (2): 605-611 Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria. All rights
More informationMulticenter Evaluation of Four Methods of Yeast Inoculum Preparation
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1988, p. 1437-1441 0095-1137/88/081437-05$02.00/0 Copyright C 1988, American Society for Microbiology Vol. 26, No. 8 Multicenter Evaluation of Four Methods of Yeast
More informationAntimicrobial susceptibility testing. EUCAST disk diffusion method
Antimicrobial susceptibility testing EUCAST disk diffusion method Version 1.0, December 18, 2009 Contents Page Abbreviations and Terminology 1 Introduction 4 2 Preparation of media 5 3 Preparation of inoculum
More informationINTRODUCTION Sanitization sterilization Antibiotics Bactericidal Bacteriostatic Antiseptics disinfectants
INTRODUCTION Infectious agents on environmental surfaces, given the correct circumstances, may potentially find their way into an unsuspecting victim. Thus, it is important to keep the surfaces we regularly
More informationFeasibility Study of Disk Diffusion Susceptibility Tests with Mueller- Hinton Broth Solidified with Gelrite, an Agar Substitute
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1985, p. 409-414 0095-1137/85/030409-06$02.00/0 Copyright (O 1985, American Society for Microbiology Vol. 21, No. 3 Feasibility Study of Disk Diffusion Susceptibility
More informationobtained from the infected and treated tissues, Fleming's2 technic of hemolytic streptococcus B. Immediately following the infection, 1.0 ml.
THE SENSITIVITY OF STREPTOCOCCI TO PENICILLIN G AFTER EXPOSURE TO THE ANTIBIOTIC IN VIVO* E. GRUNBERG, C. UNGER, AND D. ELDRIDGE Previous investigations by Grunberg, Schnitzer, and Unger3 on the topical
More informationPirbenicillin, a New Semisynthetic Penicillin with Broad- Spectrum Activity
ANTmCROBAL AGaNTs AND CHDMoTHzRA&Y, Apr. 1976, p. 668-674 Copyright ) 1976 American Society for Microbiology Vol. 9, No. 4' Printed in U.SA. Pirbenicillin, a New Semisynthetic Penicillin with Broad- Spectrum
More informationSusceptible Chromogenic Cephalosporin Reagent
JOURNAL OF CLINICAL MICROBIOLOGY, May 1982, p. 954-958 0095-1137/82/050954-05$02.00/0 Vol. 15, No. 5 In Vitro Evaluation of CENTA, a New Beta-Lactamase- Susceptible Chromogenic Cephalosporin Reagent RONALD
More informationInternational Journal of Pharma and Bio Sciences STUDIES ON EFFECT OF CEFOTAXIME AND TERMINALIA CHEBULA ON ESCHERICHIA COLI ABSTRACT
Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 STUDIES ON EFFECT OF CEFOTAXIME AND TERMINALIA CHEBULA ON ESCHERICHIA COLI ALPA RABADIA *, S.D. KAMAT AND D.V.
More informationTurbidimetric Bioassay for Carbenicillin
ANTMWICGOBAL AGENTS AND CHEMOTHEAPY, Mar. 1973, p. 364-368 Vol. 3, No. 3 Copyright 1973 American Society for Microbiology Printed in U.S.A. Turbidimetric Bioassay for Carbenicillin JOSEPH P. STANKEWICH
More informationSusceptibility Tests
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1972, p. 116-122 Copyright @ 1972 American Society for Microbiology Vol. 1, No. 2 Printed in U.S.A. Influence of Different Media and Bloods on the Results of
More informationCHAPTER 4 DISCUSSION. Many types of suitable media can be used to support the fungal growth and there is no
CHAPTER 4 DISCUSSION 4.1 Media Preparation and Subculture Many types of suitable media can be used to support the fungal growth and there is no specific medium ideally suited for the culture of species
More informationVerification of Gradient Diffusion Strips
Verification of Gradient Diffusion Strips Objectives 1. Describe gradient diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification
More informationVerification of Disk Diffusion Tests
Verification of Disk Diffusion Tests Objectives 1. Describe disk diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification of
More informationComparison of Recovery of Organisms from Blood Cultures Diluted 10% (Volume/Volume) and 20% (Volume/Volume)
JOURNAL OF CLINICAL MICROBIOLOGY, May 1982, p. 860-864 0095-1137/82/050860-05$02.00/0 Vol. 15, No. 5 Comparison of Recovery of Organisms from Blood Cultures Diluted 10% (Volume/Volume) and 20% (Volume/Volume)
More informationRapid Identification of Bacteroides fragilis with Bile and
JOURNAL OF CuNICAL MICROBIOLOGY, Apr. 1977, p. 439-443 Copyright C 1977 American Society for Microbiology Vol. 5, No. 4 Printed in U.S.A. Rapid Identification of Bacteroides fragilis with Bile and Antibiotic
More informationRapid Identification of Bacteroides fragilis with Bile and
JOURNAL OF CuNICAL MICROBIOLOGY, Apr. 1977, p. 439-443 Copyright C 1977 American Society for Microbiology Vol. 5, No. 4 Printed in U.S.A. Rapid Identification of Bacteroides fragilis with Bile and Antibiotic
More informationPenicillin Streptomycin
BTEC 4200 Name Fall 2005 Exam 2 A. Multiple choice (2 pt each) The following choices are used for questions 1 5. Trypan red Arspheniamine (Salvarsan) Sulfonamide Penicillin Streptomycin 1. This substance,
More information3.0. Materials and methods
63 3.0. Materials and methods 3.1. Plant materials and preparation of extracts Salacia oblonga plants were collected from Western Ghats, Karnataka, India. S. oblonga (RRCBI 7881) authentication was done
More informationInfluence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 1998, p. 1207 1212 Vol. 42, No. 5 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology Influence of Test Conditions on Antifungal Time-Kill
More informationThe Cat s Out of the Bag: Microbiological Investigations of Acute Transfusion Reactions.
The Cat s Out of the Bag: Microbiological Investigations of Acute Transfusion Reactions. Philippe Lagacé-Wiens, MD FRCPC, DTM&H plagacewiens@sharedhealthmb.ca COI declaration I have no conflicts, real
More informationSetting Clinical Breakpoints/ECOFFS
23 rd August 2016 Setting Clinical Breakpoints/ECOFFS Robin A Howe Antimicrobial use in Primary Care An E. coli is grown from blood cultures Cefuroxime MIC 2mg/L Zone around CXM 30ug disc 27mm Is it sensitive?
More informationSusceptibility Testing
APPLTE MICROBIOLOGY, Feb. 1970, p. 259-263 Copyright 1970 American Society for Microbiology Vol. 19, No. 2 Printed in U.S.A. In Vitro Antibacterial Activity of Minocycline and Effect of Agar Medium Utilized
More informationTest Method for Efficacy of Copper Alloy Surfaces as a Sanitizer
Test Method for Efficacy of Copper Alloy Surfaces as a Sanitizer Test Organisms: Staphylococcus aureus (ATCC 6538) Enterobacter aerogenes (ATCC 13048) Pseudomonas aeruginosa (ATCC 15442) Methicillin Resistant
More informationAbstract. Mary Jane Ferraro, PhD, MPH Jana M. Swenson, MMSc
January 2009 Vol. 29 No. 2 Replaces M07-A7 Vol. 26 No. 2 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard Eighth Edition This document addresses
More information(see Table 1, footnotes) developed a protocol. four phases. In phase 1, the investigators famiiarized
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1980, p. 375-390 0095-1137/80/09-0375/16$02.00/0 Vol. 12, No. 3 Clinical Laboratory Evaluation of the Abbott MS-2 Automated Antimicrobial Susceptibiity Testing System:
More informationValidation of the Automated Reading and Incubation System with Sensititre Plates for Antimicrobial Susceptibility Testing
JOURNAL OF CLINICAL MICROBIOLOGY, May 2003, p. 1951 1956 Vol. 41, No. 5 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.5.1951 1956.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationTest Method for the Continuous Reduction of Bacterial Contamination on Copper Alloy Surfaces
Test Method for the Continuous Reduction of Bacterial Contamination on Copper Alloy Surfaces Test Organisms: Staphylococcus aureus (ATCC 6538) Enterobacter aerogenes (ATCC 13048) Pseudomonas aeruginosa
More informationAntibiotic Susceptibility of Anaerobic Bacteria
AwNrIcRoBuL AIGENTS AND CHUMOT R"PY, Mar. 1973, p. 35O-356 Copyright 1973 American Society for Microbiology Vol. S, No. 3 Prind in U.S.A. Modified Broth-Disk Method for Testing the Antibiotic Susceptibility
More informationAntibiotic Susceptibility of Anaerobic Bacteria
AwNrIcRoBuL AIGENTS AND CHUMOT R"PY, Mar. 1973, p. 35O-356 Copyright 1973 American Society for Microbiology Vol. S, No. 3 Prind in U.S.A. Modified Broth-Disk Method for Testing the Antibiotic Susceptibility
More informationUse of Molecular Assays for Resistance Detection
Use of Molecular Assays for Resistance Detection Antimicrobial resistance and susceptibility are complex, and current in vitro methods have been developed to predict a microorganism s response to antibacterial
More informationIMPLEMENTATION OF EUCAST BREAKPOINTS
IMPLEMENTATION OF EUCAST BREAKPOINTS BELGIAN /GDL COUNTDOWN UNTIL 1ST JANUARY 2010 : 64 DAYS Pierrette Melin, CHU of Liege Coordinator of the SBIMC-BVIKM/EUCAST microbiology working party 1 Introduction
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 20776-1 First edition 2006-11-15 Clinical laboratory testing and in vitro diagnostic test systems Susceptibility testing of infectious agents and evaluation of performance of
More informationCONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS
CONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS Specific control measures can be used to kill or inhibit the growth of microorganisms. A procedure which leads to the death of cells is broadly
More informationR. N. JONES Clinical Microbiology Laboratory, Kaiser Foundation Hospital Laboratories Clackamas, Oregon 97015, U.S.A.
VOL. XXX NO. THE JOURNAL OF ANTBOTCS 7 ACLLN (T-), A NEW SEMSYNTHETC PENCLLN: N VTRO ANTMCROBAL ACTVTY COMPARSON WTH ENCLLN, CLLN, CLLN, LOTHN, ANDOLE AND TN R. N. JONES Clinical Microbiology Laboratory,
More informationAntimicrobial Drug Susceptibility Testing:
ANTMCROBAL AGENTs AND CHEMOTHERAPY, Jan. 1978, p. 61-69 pyright 1978 American Society for Microbiology Vol. 13, No. 1 Printed in U.S.A. Evaluation of the Micro-Media System for Quantitative Antimicrobial
More informationM. Ben-David 1, O. Hammer 1, A.Scinderman 1, Y. Gluckman-Yavo 1, M. Fridman 1, D. Gohman 1, G. Ingber 1 and E. Zahavy 2
441 Rapid Gram Negative Antimicrobial Susceptibility Testing Directly from Positive Blood Culture based on a Unique Spectral Intensity Ratio Analysis via Single Fluorescence Membrane Dye Staining and Flow
More informationInternational Journal of Pharmacy
International Journal of Pharmacy Journal Homepage: http://www.pharmascholars.com Review Article CODEN: IJPNL6 ANTIBIOTIC SUSCEPTIBILITY TESTING: A REVIEW ON CURRENT PRACTICES Uddhav S Bagul*and Sivagurunathan
More informationsuch a specimen is often difficult t o obtain.
Assays of Antimicrobial Agents in Serum by Josephine A. Morello, Ph.D. Under certain clinical circumstances, it will be necessary to measure the antibiotic levels in the b l o o d of a patient being given
More informationApproximately 20% of the responding CLSI membership whose hospitals had greater than 200 beds was performing antifungal testing.
Vol. 28 No. 14 Replaces M27-A2 Vol. 22 No. 15 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard Third Edition This document addresses the selection and
More informationComparison of results from two antibiotic susceptibility testing trials that formed part of the
J Clin Pathol 1984;37:321-328 Comparison of results from two antibiotic susceptibility testing trials that formed part of the United Kingdom national external quality assessment scheme JJS SNELL, DFJ BROWN,*
More informationIsolation of Lac+ Mutants from a Lac- Strain of Escherichia coli, by the Replica Plating Technique
586 BANI^, S. (1958). J. gen. Microbiol. 18, 586-590 Isolation of Lac+ Mutants from a Lac- Strain of Escherichia coli, by the Replica Plating Technique BY S. BANIC Institute of Microbiology, Medical Faculty,
More informationBiofilm Protocol Optimization For Pseudomonas aeruginosa. Introduction. Materials and Methods. Culture Media, Incubation Time, and Biofilm Measurement
Biofilm Protocol Optimization For Pseudomonas aeruginosa Culture Media, Incubation Time, and Biofilm Measurement Introduction In addition to the conventional arsenal of antibiotic resistance mechanisms
More informationTHE USE OF SEKISUI DIAGNOSTICS PENICILLINASE
THE USE OF SEKISUI DIAGNOSTICS PENICILLINASE AND β-lactamase PRODUCTS INTRODUCTION The aim of this guide is to outline the general procedures for the use of Sekisui Diagnostics Penicillinase and β-lactamase
More informationin Alveolar Macrophages
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 1989, p. 2132-2136 0066-4804/89/122132-05$02.00/0 Copyright 1989, American Society for Microbiology Vol. 33, No. 12 WIN 57273 Is Bactericidal for Legionella
More informationPolymicrobial Infection in Mice
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUlY 1993, P. 1531-1535 0066-4804/93/071531-05$02.00/0 Copyright 1993, American Society for Microbiology Vol. 37, No. 7 Use of Cephalosporins for Prophylaxis and
More informationControl Issued by: LABORATORY MANAGER Original Date: April 11, 2001 Approved by: Laboratory Director Revision Date: February 27, 2004
Section: Policy # MI\QC\05\v02 Page 1 of 5 Subject Title: Kirby Bauer Quality Control Issued by: LABORATORY MANAGER Original Date: April 11, 2001 Approved by: Laboratory Director Revision Date: February
More information